Published Nov 10, 2026, 12:40 PM ET · Updated 3 days ago · 1 source
MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock
Seeking Alpha
·
Original Report
MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock
MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock